Now showing items 1-1 of 1

    • UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy. 

      Hanna, GG; Murray, L; Patel, R; Jain, S; Aitken, KL; Franks, KN; van As, N; Tree, A; Hatfield, P; Harrow, S; McDonald, F; Ahmed, M; Saran, FH; Webster, GJ; Khoo, V; Landau, D; Eaton, DJ; Hawkins, MA (2018-01)
      Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of these involve the treatment of oligometastatic disease at different locations in the body. Members of all the trial management ...